News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 289–324
- Matches
- 8319
- Sources here
- 23
- Companies here
- 28
Search results
Stored financial headlines
Active search
8319 matching headlines
Ticker or company: RNAMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Philip Morris International Inc. (NYSE:PM) Given Consensus Recommendation of "Moderate Buy" by Analysts
Analysts have issued a "Moderate Buy" consensus rating for Philip Morris International (NYSE:PM), with an average 12-month price target of $205.89. The company recently surpassed Q2 earnings expectations, reporting adjusted EPS of $2.20 and revenue of $11.19 billion, and has declared a quarterly dividend …
PM
main company
Sharemaestro market context
Trend signal active
52 weeks +14.0% · Next-week setup positive 61.2%
SEPTERNA, INC. : JP MORGAN RAISES TARGET PRICE TO $48 FROM $38
J.P. Morgan has raised its target price for SEPTERNA, INC. (SEPN.O) to $48 from the previous $38. This update reflects the analyst's revised outlook on the company's valuation. The article states that this content solely reflects the author's opinion and is not investment advice.
SEPN
main company
Sharemaestro market context
Trend signal active
52 weeks +271.1%
WESCO EVP Akash Khurana sells $1.25m in company stock By Investing.com
WESCO Executive Vice President Akash Khurana sold company stock valued at approximately $1.25 million on August 17, 2026, across various transactions at weighted average prices between $366.1 and $368.27 per share. Despite WCC shares delivering a 63% return over the past year, InvestingPro analysis …
WCC
main company
Sharemaestro market context
Trend signal active
52 weeks +63.9%
Elon Musk Says mRNA Has 'Tremendous Promise,' Turning Disease Into a 'Software Problem,' as Moderna Stock Rockets 177% on Cancer Vaccine Breakthrough
Elon Musk said Wednesday that mRNA technology could fundamentally change how diseases are treated, a shift that would make medicine more of a software problem than a biological one, as Moderna Inc. (NASDAQ:MRNA) and Merck & Co Inc. (NYSE:MRK) posted a major cancer-vaccine trial …
Sharemaestro market context Trend signal active 52 weeks +114.7%SCE Brings Wildfire Recovery Compensation Program Directly to Communities Ahead of Nov. 30 Deadline
Southern California Edison (SCE) is hosting community events to help those impacted by the Eaton Fire learn about and apply for the Wildfire Recovery Compensation Program before the Nov. 30 deadline. To date, the program has extended over $830 million in offers to more …
EIX
main company
Sharemaestro market context
Trend signal active
52 weeks +34.0% · Next-week setup positive 56.2%
Greenridge Global Maintains China Yuchai International(CYD.US) With Buy Rating, Maintains Target Price $60
Greenridge Global has reiterated its Buy rating on China Yuchai International (CYD.US) and maintained a target price of $60. This continued positive outlook suggests the firm believes in the company's future performance and valuation.
CYD
main company
Sharemaestro market context
Price below Trend Line
52 weeks +44.7% · Next-week setup positive 62.1%
Miami International Holdings (NYSE: MIAX) holder plans sale of 149,700 shares
Gallagher Investments LLC, a holder of Miami International Holdings (MIAX) stock, has filed a Form 144 indicating an intent to sell up to 149,700 shares of common stock. The sale will be executed through Morgan Stanley Smith Barney LLC, with the shares originating from …
MIAX
main company
Sharemaestro market context
Price above Trend Line
52 weeks +29.8% · Next-week setup positive 56.9%
Honeywell Technologies announces new CEO in Process Automation sector
Honeywell Technologies has announced that Billal Hammoud will become the new president and CEO of its Process Automation & Technology sector, effective October 1. Hammoud, who previously led the company's Building Automation division, will succeed Ken West. Juan Picon will take over Hammoud's former …
HON
main company
Sharemaestro market context
Price below Trend Line
52 weeks +8.0% · Next-week setup positive 56.0%
Ascentage Pharma H1FY26 Results: Revenue rises 29% to $44.5 million
Ascentage Pharma Group International reported H1FY26 revenue of US$44.5 million, significantly beating analyst estimates, and a better-than-expected EPS loss of US$0.32. However, the company's net loss widened to US$120.4 million due to substantial increases in R&D and selling expenses, reflecting a heavy investment phase. …
Sharemaestro market context Price below Trend Line 52 weeks -60.3% · Next-week setup negative 44.0%